Skip to content
DataLookout
Menu

CSAPG-37NCT05920382

Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain.

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 1, 2026 to Sep 1, 2027 Show 5 more changesShow less
    • Eligibility criteria expanded, about 10 words
    • Study completion pushed from Dec 1, 2027 to Dec 1, 2028
    • Secondary endpoints: details revised at 3 of 7 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Notable Primary completion date: Sep 1, 2025 to Sep 1, 2026
    • Start date: Sep 29, 2023 to Sep 25, 2023
    • Publications: 15 to 1
    v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 15, 2023 to Sep 29, 2023
    v3
  4. Minor Secondary endpoints: 6 to 7v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change Pain and Disability measured by Western Ontario and McMaster Universities Arthritis Index, (WOMAC).
Timeframe: 3 month

Secondary (7)

Changes in pain measured by the Numeric Rating Scale for pain. (NRS)
Neuropathic pain measured by Neuropathic Pain questionnaire (DN4)
Depression and anxiety measured by Hospital Anxiety and Depression Scale (HADS)
Degree of satisfaction with the procedure performed measured by categorical satisfaction scale of our hospital's pain unit.
Safety from the applied treatment measured by number of adverse events associated with the technique.
Show 2 moreShow less
Duration (YEARS) of pain and treatment outcomes measured by Numeric Rating Scale for pain.
Duration (YEARS) of pain and treatment outcomes measured by WOMAC questionnaire.

Arms and interventions

Radiofrequency armExperimental

After identifying the nerves to be treated via ultrasound and confirming with neurostimulation, 1 ml of 2% lidocaine will be administered, followed by radiofrequency ablation. The physical parameters used are as follows: 90 seconds, 80 degrees Celsius, with a 22g needle with an active tip of 10 mm.

Control armSham comparator

In the same manner as with the RF group, the nerves to be treated are identified via ultrasound and confirmed by neurostimulation. Subsequently, sham radiofrequency is performed for 90 seconds.

Procedures: Radiofrequency ablation of peripheral nerves.

Sites

1 site in 1 country

  • Consorci Sanitari Alt'Pènedes i GarrafBarcelona, Catalonia, Spain